Biologics Market Report:
According to IMARC Group latest report titled “Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on biologics market segments. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global biologics market size reached US$ 321.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 535.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.
Biologics, also known as biological medications, represent disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of elements of living organisms. They include several products, such as genes, tissues, allergens, vaccines, blood components, cells, and recombinant proteins, derived from animals, birds, insects, humans, plants, and microorganisms. Biologics modify human hormones and cells and control the production of vital proteins while creating substances to activate and suppress the immune system. They also change the manner of operation of natural intracellular and cellular actions. In addition, biologics are utilized to treat various illnesses and conditions, including ulcerative colitis, Crohn’s disease, rheumatoid arthritis, and other autoimmune ailments.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/biologics-market/requestsample
Market Trends:
The escalating cases and diagnosis of chronic diseases have necessitated the availability of advanced diagnostics and treatment drugs, which are among the primary factors driving the biologics market. Besides this, the launch of several policies by the government bodies to promote the healthcare sector and ensure the availability of innovative medicine, owing to the sudden outbreak of the COVID-19 pandemic across the globe, is further augmenting the market growth. Moreover, the introduction of advanced methods of manufacturing biologics genetically to target a specific part of the immune system that fuels inflammation is also catalyzing the global market.
Apart from this, scientists and researchers are extensively investigating species and expression techniques to enhance the productivity of biological variants, which are acting as significant growth-inducing factors. Furthermore, the inflating investments of the leading pharmaceutical companies in research and development (R&D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn’s disease are expected to bolster the biologics market in the coming years.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca plc
- Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
- Johnson & Johnson
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi
Biologics Market Segmentation:
Our report has categorized the market based on region, source, product, disease and manufacturing.
Breakup by Source:
- Microbial
- Mammalian
- Others
Breakup by Product:
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Antisense, RNAi and Molecular Therapy
- Others
Breakup by Disease:
- Oncology
- Immunological Disorders
- Cardiovascular Disorders
- Hematological Disorders
- Others
Breakup by Manufacturing:
- Outsourced
- In-House
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
